Your browser doesn't support javascript.
loading
Co-Targeting of MDM2 and CDK4/6 with Siremadlin and Ribociclib for the Treatment of Patients with Well-Differentiated or Dedifferentiated Liposarcoma: Results from a Proof-of-Concept, Phase Ib Study.
Abdul Razak, Albiruni R; Bauer, Sebastian; Suarez, Cristina; Lin, Chia-Chi; Quek, Richard; Hütter-Krönke, Marie Luise; Cubedo, Ricardo; Ferretti, Stephane; Guerreiro, Nelson; Jullion, Astrid; Orlando, Elena J; Clementi, Giorgia; Sand Dejmek, Janna; Halilovic, Ensar; Fabre, Claire; Blay, Jean-Yves; Italiano, Antoine.
Afiliación
  • Abdul Razak AR; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Bauer S; Universitätsklinikum Essen Klinik für Innere Medizin, Essen, Germany.
  • Suarez C; Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Lin CC; National Taiwan University Hospital, Taipei, Taiwan.
  • Quek R; Parkway Cancer Centre, Singapore.
  • Hütter-Krönke ML; University Hospital Ulm, Department of Internal Medicine III, Ulm, Germany.
  • Cubedo R; Hospital Universitario Puerta de Hierro, Madrid, Spain.
  • Ferretti S; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Guerreiro N; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Jullion A; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Orlando EJ; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
  • Clementi G; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Sand Dejmek J; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Halilovic E; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
  • Fabre C; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Blay JY; Centre Léon Berard, Lyon, France.
  • Italiano A; Institut Bergonié, Bordeaux, France.
Clin Cancer Res ; 28(6): 1087-1097, 2022 03 15.
Article en En | MEDLINE | ID: mdl-34921024

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Liposarcoma Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Liposarcoma Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Canadá